InvestorsHub Logo

mrplmer

11/27/23 12:59 PM

#440422 RE: falconer66a #440420

What is the name of that Journal?

Do you mean would he obfuscate?

boi568

11/27/23 1:03 PM

#440424 RE: falconer66a #440420

The full data was disclosed to the EMA and was strong enough to persuade them to have Anavex enter their regulatory drug approval procedure. That same data will also look good when it is published in a journal.

Steady_T

11/27/23 2:09 PM

#440456 RE: falconer66a #440420

He rewording of this reply suggests to me that he knows when it will be published.

"...We have met the European Agency several times in meetings and we have shared the data which is not yet published, which is the published date of -- the planned published communication of the full data of the Alzheimer Phase 2b/3 study.

BAR123

11/27/23 3:36 PM

#440475 RE: falconer66a #440420

Speaking of the peer review journal, does anyone know how and when they publish these types of articles? Meaning is there a set timeline for when they publish , ie for example does the New England Journal of Medicine publish each month on the first day of the month. Does the online version come out before the print edition? Do we think that the company will put out a press release based on the release of the article or just let the data and the authors speak for themselves?